Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
about
Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugsCalling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.A PREVIOUSLY UNKNOWN UNIQUE CHALLENGE FOR INHIBITORS OF SYK ATP-BINDING SITE: ROLE OF SYK AS A CELL CYCLE CHECKPOINT REGULATORRAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.Novel methods and approaches to acute lymphoblastic leukemia drug discovery.Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.Syk inhibitors in clinical development for hematological malignancies.Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.Suppression of Spleen Tyrosine Kinase (Syk) by Histone Deacetylation Promotes, Whereas BAY61-3606, a Synthetic Syk Inhibitor Abrogates Colonocyte Apoptosis by ERK Activation.Anticancer drugs: Hitting SYK in B-ALL leukaemia.Crystal Structures of Spleen Tyrosine Kinase in Complex with Two Novel 4-Aminopyrido[4,3-d] Pyrimidine Derivative Inhibitors.Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays.
P2860
Q27726998-B07CCAA0-A532-4965-B2BA-38D1C8810CAFQ34625171-D89C69D6-8317-4D84-9E8E-503597805E1AQ34653474-D32701C4-8C15-41E7-A5EF-373B165F1901Q36569363-F83565E4-6061-412F-A03E-461F63F4C6FAQ38248461-30133574-E86D-4165-99D3-DDBC862AC676Q38796456-FF0CD53E-7299-4A12-BD66-C9B08BBE2612Q42011012-E32576C5-2406-489B-BD55-24EDF2571BC3Q46364067-046544B0-7FF5-413F-A36E-D17D0CDDF1ABQ51706615-270D1125-1E4A-4449-881D-75CBF9A026FDQ54343413-8B7EAA0C-B625-453E-978D-98647B6DB1D3Q54976524-99FDAEB8-14C0-47C6-A371-01E5F4EE76F0Q54979889-F1C4395D-8B65-43E3-A5CB-F0A98F056B90
P2860
Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Therapeutic potential of splee ...... acute lymphoblastic leukemia.
@en
Therapeutic potential of splee ...... acute lymphoblastic leukemia.
@nl
type
label
Therapeutic potential of splee ...... acute lymphoblastic leukemia.
@en
Therapeutic potential of splee ...... acute lymphoblastic leukemia.
@nl
prefLabel
Therapeutic potential of splee ...... acute lymphoblastic leukemia.
@en
Therapeutic potential of splee ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P1476
Therapeutic potential of splee ...... l acute lymphoblastic leukemia
@en
P2093
Cynthia J Guidos
Eniko Papp
Ildiko Grandal
Irina R Matei
Jayne S Danska
Johann K Hitzler
Joseph Beyene
Mark D Minden
Paul E Kowalski
Tatiana Perova
P2860
P304
P356
10.1126/SCITRANSLMED.3008661
P407
P577
2014-05-01T00:00:00Z